Frankfurt - Delayed Quote EUR
Medpace Holdings, Inc. (01P.F)
265.50
0.00
(0.00%)
As of 8:05:02 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 5.9M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
CARLEY BRIAN T Director | -- | Direct | -- | Mar 31, 2025 |
MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Mar 31, 2025 |
KRAFT ROBERT O Director | -- | Direct | -- | Mar 31, 2025 |
TROENDLE AUGUST J Chief Executive Officer | Conversion of Exercise of derivative security at price 54.74 - 107.93 per share. | Direct | 24,458,835 | Mar 7, 2025 |
EWALD STEPHEN P General Counsel | Purchase at price 326.11 per share. | Direct | 652 | Feb 27, 2025 |
CARLEY BRIAN T Director | Conversion of Exercise of derivative security at price 42.62 per share. | Direct | 346,373 | Feb 24, 2025 |
CARLEY BRIAN T Director | Sale at price 345.59 per share. | Direct | 1,383,397 | Feb 24, 2025 |
CARLEY BRIAN T Director | -- | Direct | -- | Dec 31, 2024 |
MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Dec 31, 2024 |
KRAFT ROBERT O Director | -- | Direct | -- | Dec 31, 2024 |
GEIGER JESSE J President | Conversion of Exercise of derivative security at price 32.05 per share. | Direct | 480,750 | Dec 6, 2024 |
BURWIG SUSAN ELIZABETH Officer | Conversion of Exercise of derivative security at price 32.05 per share. | Direct | 240,375 | Nov 19, 2024 |
CARLEY BRIAN T Director | -- | Direct | -- | Sep 30, 2024 |
MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Sep 30, 2024 |
KRAFT ROBERT O Director | -- | Direct | -- | Sep 30, 2024 |
KRAFT ROBERT O Director | Conversion of Exercise of derivative security at price 42.62 per share. | Direct | 346,373 | Aug 23, 2024 |
KRAFT ROBERT O Director | Sale at price 390.73 per share. | Direct | 3,175,463 | Aug 23, 2024 |
BURWIG SUSAN ELIZABETH Officer | Conversion of Exercise of derivative security at price 90.65 per share. | Direct | 4,532,500 | Aug 5, 2024 |
CARLEY BRIAN T Director | -- | Direct | -- | Jun 28, 2024 |
MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Jun 28, 2024 |
KRAFT ROBERT O Director | -- | Direct | -- | Jun 28, 2024 |
BURWIG SUSAN ELIZABETH Officer | Sale at price 401.20 per share. | Direct | 3,081,617 | Jun 5, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 395.22 - 395.49 per share. | Direct | 3,828,058 | May 28, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.00 per share. | Direct | 22,000 | May 22, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.19 per share. | Direct | 1,608,764 | May 20, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 403.09 - 405.13 per share. | Direct | 15,924,222 | May 16, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 402.89 per share. | Direct | 1,996,723 | May 10, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.17 - 400.58 per share. | Direct | 3,310,566 | May 9, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 401.73 - 404.48 per share. | Direct | 21,129,347 | May 7, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.44 - 401.56 per share. | Direct | 6,553,671 | May 2, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.31 - 400.69 per share. | Direct | 6,782,987 | Apr 30, 2024 |
CARLEY BRIAN T Director | -- | Direct | -- | Mar 28, 2024 |
MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Mar 28, 2024 |
KRAFT ROBERT O Director | -- | Direct | -- | Mar 28, 2024 |
BURWIG SUSAN ELIZABETH Officer | Sale at price 403.00 per share. | Direct | 41,106 | Mar 15, 2024 |
KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 84.36 per share. | Direct | 42,180 | Mar 14, 2024 |
KEATING ASHLEY M. Director | Sale at price 409.87 per share. | Direct | 102,468 | Mar 14, 2024 |
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 408.71 - 412.98 per share. | Direct | 82,321,250 | Mar 8, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 408.71 - 412.98 per share. | Indirect | 82,321,250 | Mar 8, 2024 |
KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 54.99 per share. | Direct | 25,955 | Mar 7, 2024 |
KEATING ASHLEY M. Director | Sale at price 415.00 per share. | Direct | 195,880 | Mar 7, 2024 |
GEIGER JESSE J President | Conversion of Exercise of derivative security at price 90.65 per share. | Direct | 3,626,000 | Mar 5, 2024 |
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 402.70 - 403.12 per share. | Direct | 40,291,000 | Mar 5, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 402.70 - 403.12 per share. | Indirect | 40,291,000 | Mar 5, 2024 |
GEIGER JESSE J President | Sale at price 403.03 per share. | Direct | 8,996,033 | Mar 4, 2024 |
MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 393.71 - 401.88 per share. | Direct | 40,024,600 | Mar 1, 2024 |
EWALD STEPHEN P General Counsel | Sale at price 393.50 - 400.79 per share. | Direct | 597,923 | Mar 1, 2024 |
TROENDLE AUGUST J Chief Executive Officer | Sale at price 393.71 - 401.88 per share. | Indirect | 40,024,600 | Mar 1, 2024 |
GEIGER JESSE J President | Sale at price 393.50 per share. | Direct | 1,006,586 | Feb 29, 2024 |
KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 54.99 per share. | Direct | 27,495 | Feb 28, 2024 |
Related Tickers
ILU.MU Illumina Inc
67.89
-0.24%
300347.SZ Hangzhou Tigermed Consulting Co., Ltd
45.05
-0.97%
IJF.MU Icon PLC
128.05
+2.56%
603127.SS Joinn Laboratories(China)Co.,Ltd.
15.54
+0.65%
EZB.F Enzo Biochem, Inc.
0.4240
+19.77%
0RUG.IL bioMérieux S.A.
114.50
+0.53%
SLV.WA Selvita S.A.
33.50
+3.72%
TN8.DE Thermo Fisher Scientific Inc.
377.20
+1.25%
ILU.F Illumina, Inc.
67.68
-0.06%
IJF.F ICON Public Limited Company
125.75
-1.49%